Title: AMEND S e n ate Bill No. 421* House Bill No. 1239
Official Title: AMEND S e n ate Bill No. 421* House Bill No. 1239
Number of Sections: 3
Source: versions - Amendment SA0095
Media Type: application/pdf
Strikethrough Detection: 2 sections found

================================================================================

Section 1:
Senate Judiciary 1
Amendment No. 1 to SB0421
Gardenhire
Signature of Sponsor
by deleting all language after the enacting clause and substituting:

Section 2:
SECTION 1. Tennessee Code Annotated, Section 53-11-311, is amended by adding
the following as a new subsection:
(j)
(1) Notwithstanding this title to the contrary, and except as otherwise
provided in this section, a physician licensed under title 63, chapter 6 or 9, is the
only healthcare provider authorized to prescribe a buprenorphine product for a
federal food and drug administration-approved use in recovery or medication-
assisted treatment.
(2) Healthcare providers not licensed pursuant to title 63, chapter 6 or 9,
and who are otherwise permitted to prescribe Schedule II or III drugs under this
title are prohibited from prescribing a buprenorphine product for the treatment of
opioid use disorder unless the provider:
(A) Has an active registration with the federal drug enforcement
agency;
(B) Is employed by or contracts with a state correctional facility,
as defined in ยง 41-21-206, or a county or municipal jail to provide
healthcare services;
(C) Has adopted clinical protocols for the facilitation or
continuance of medication-assisted treatment for persons who are
SA0095
005070
- 1 -
incarcerated in or to be released from such state correctional facility or
county or municipal jail;
(D) Writes prescriptions for buprenorphine to no more than fifty
(50) patients at any given time;
(E) Collaborates with a physician who reviews one hundred
percent (100%) of the charts of the patients being prescribed a
buprenorphine product;
(F) Is supervised by or collaborates with a physician who is
limited to the supervision of, or collaboration for, a maximum of five (5)
licensed nurse practitioners or physician assistants;
(G) Does not write any prescription for a buprenorphine product
that exceeds a sixteen-milligram daily equivalent;
(H) Has had no limitations or conditions imposed on the provider's
license by the provider's licensing authority within the previous three (3)
years;
(I) Enters all prescriptions into the controlled substance
monitoring database; and
(J) Prescribes buprenorphine products only to patients who are
treated through the correctional facility that employs the provider.

Section 3:
SECTION 2. This act takes effect July 1, 2025, the public welfare requiring it.
- 2 - 005070
[DELETED:  a HS]
[DELETED:  -0S]


================================================================================

Raw Text:
Senate Judiciary 1
Amendment No. 1 to SB0421
Gardenhire
Signature of Sponsor
AMEND S e n ate Bill No. 421* House Bill No. 1239
by deleting all language after the enacting clause and substituting:
SECTION 1. Tennessee Code Annotated, Section 53-11-311, is amended by adding
the following as a new subsection:
(j)
(1) Notwithstanding this title to the contrary, and except as otherwise
provided in this section, a physician licensed under title 63, chapter 6 or 9, is the
only healthcare provider authorized to prescribe a buprenorphine product for a
federal food and drug administration-approved use in recovery or medication-
assisted treatment.
(2) Healthcare providers not licensed pursuant to title 63, chapter 6 or 9,
and who are otherwise permitted to prescribe Schedule II or III drugs under this
title are prohibited from prescribing a buprenorphine product for the treatment of
opioid use disorder unless the provider:
(A) Has an active registration with the federal drug enforcement
agency;
(B) Is employed by or contracts with a state correctional facility,
as defined in ยง 41-21-206, or a county or municipal jail to provide
healthcare services;
(C) Has adopted clinical protocols for the facilitation or
continuance of medication-assisted treatment for persons who are
SA0095
005070
- 1 -

incarcerated in or to be released from such state correctional facility or
county or municipal jail;
(D) Writes prescriptions for buprenorphine to no more than fifty
(50) patients at any given time;
(E) Collaborates with a physician who reviews one hundred
percent (100%) of the charts of the patients being prescribed a
buprenorphine product;
(F) Is supervised by or collaborates with a physician who is
limited to the supervision of, or collaboration for, a maximum of five (5)
licensed nurse practitioners or physician assistants;
(G) Does not write any prescription for a buprenorphine product
that exceeds a sixteen-milligram daily equivalent;
(H) Has had no limitations or conditions imposed on the provider's
license by the provider's licensing authority within the previous three (3)
years;
(I) Enters all prescriptions into the controlled substance
monitoring database; and
(J) Prescribes buprenorphine products only to patients who are
treated through the correctional facility that employs the provider.
SECTION 2. This act takes effect July 1, 2025, the public welfare requiring it.
- 2 - 005070

[DELETED:  a HS]
[DELETED:  -0S]